Our metabolomics data show that TCA cycle intermediates are upregulated in ALS; however, it remains unclear whether this is a direct consequence of TDP-43 proteinopathy or a compensatory mechanism. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.